Is Itching a Sign of Cancer?

Itchy skin has many causes, including dryness and allergies, but only rarely does it signal that a person has cancer.

This symptom may occur as a result of complications of the disease, and itchy, flaky skin and rashes are common side effects of some cancer drugs. Most skin cancers, such as malignant melanoma, don’t normally cause itching.

IMG_6731-2One form of cancer in which itching is a prominent sign is polycythemia vera, one of several blood cancers known as myeloproliferative disorders. People with this disease may experience itchiness particularly after a warm bath or hot shower, but this is only one of many symptoms associated with polycythemia vera. Others are trouble breathing when lying down, dizziness, headache, fatigue, and others.

Scaly skin and red rashes may be an early sign of mycosis fungoides or Sezary Syndrome, which are forms of cutaneous T-cell lymphoma. Mycosis fungoides goes through a series of phases, beginning with red rashes that may last for months or years, followed by the development of bumps or hardened lesions on the skin, and eventually tumors that form on the skin and may be infected.

Pancreatic cancer is another disease where patients may experience itching, but itching in itself is not a sign of pancreatic cancer. Pancreatic cancer patients may experience itching if their tumor blocks the bile duct and causes jaundice, says Robert Mayer, MD, of Dana-Farber’s Gastrointestinal Cancer Treatment Center. When this occurs, chemicals in the bile can leak into the skin and cause itching.

Some cancer treatments may cause itching or rashes over the entire body or in isolated areas. This may be result from a hypersensitivity reaction during chemotherapy infusion. In some cases, itching may be a chronic side effect of treatments, including biologic agents, radiation therapy, and a variety of targeted drugs.

Comments Sort By Newest

4 thoughts on “Is Itching a Sign of Cancer?

  1. This is the same cancer my daughter had and the itchiness lasted into her second treatment as well. She had also developed calloused palms and soles of her feet were very itchy. She broke a few of my floor registers by trying to scratch the bottoms of her feet.

  2. The article fails to mention the likelihood of the itchiness being attributed to mild eczema. You can confirm that with a qualified dermatologist. There is a prescription for that.

  3. Itching is a very common sign of Hodgkin Lymphoma. My daughter had it as one of the first symptoms and lasted until second round of chemo.

  4. This is the same cancer my daughter had and the itchiness lasted into her second treatment as well. She had also developed calloused palms and soles of her feet were very itchy. She broke a few of my floor registers by trying to scratch the bottoms of her feet.

  5. Itching is a very common sign of Hodgkin Lymphoma. My daughter had it as one of the first symptoms and lasted until second round of chemo.

  6. The article fails to mention the likelihood of the itchiness being attributed to mild eczema. You can confirm that with a qualified dermatologist. There is a prescription for that.

Comments are closed.

Make An Appointment

For adults: 877-442-9599

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

All content in these blogs is provided by independent writers and does not represent the opinions or advice of Dana-Farber Cancer Institute or its partners.

Latest Tweets

Dana-Farber @danafarber
TOMORROW 5/23: The #DFCImammovan will be at Bowdoin Street Health Center. Call ☎️ 617.632.1974 or visit:… https://t.co/Ai3DKiBGHi
Dana-Farber @danafarber
ICYMI: We chatted with Dr. Mark Kieran about pediatric #braintumors on Facebook Live today. Watch:… https://t.co/8V5ONsp00z

Republish our posts on your blog

Interested in sharing one of our stories on your blog? Feel free to republish this content! We just ask that you credit Dana-Farber, link to the original article, and refrain from making edits that change the original context. Questions? Email the editors at insight_blog@dfci.harvard.edu.